Bessemer Group Inc. Decreases Stock Position in Danaher Corporation $DHR

Bessemer Group Inc. cut its holdings in Danaher Corporation (NYSE:DHR) by 98.3% during the 1st quarter, HoldingsChannel.com reports. The fund owned 36,441 shares of the conglomerate’s stock after selling 2,060,465 shares during the period. Bessemer Group Inc.’s holdings in Danaher were worth $6,910,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Elevated Capital Advisors LLC purchased a new position in shares of Danaher in the fourth quarter worth $26,000. Hilton Head Capital Partners LLC purchased a new stake in shares of Danaher during the fourth quarter valued at $27,000. Clal Insurance Enterprises Holdings Ltd increased its holdings in Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock worth $29,000 after buying an additional 53 shares in the last quarter. JPL Wealth Management LLC bought a new stake in Danaher in the 3rd quarter worth about $25,000. Finally, WFA of San Diego LLC purchased a new position in Danaher in the 2nd quarter worth about $26,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on DHR. Jefferies Financial Group restated a “buy” rating and set a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. Piper Sandler started coverage on shares of Danaher in a report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. TD Cowen lowered their price objective on shares of Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. Argus dropped their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Friday, April 24th. Finally, Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $231.64.

Danaher Trading Down 0.1%

Shares of DHR stock opened at $203.65 on Monday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The company has a market cap of $144.14 billion, a price-to-earnings ratio of 39.39, a PEG ratio of 2.51 and a beta of 0.79. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The firm has a fifty day moving average price of $183.27 and a 200-day moving average price of $198.25.

Danaher (NYSE:DHR) last announced its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue for the quarter was up 3.7% compared to the same quarter last year. During the same period last year, the firm earned $1.88 EPS. As a group, equities analysts predict that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s payout ratio is presently 30.95%.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.